32.75 USD
+0.98 (+3.08%)
32.75 USD
0 (0%)
Overall INDV gets a fundamental rating of 5 out of 10. We evaluated INDV against 192 industry peers in the Pharmaceuticals industry. While INDV belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. INDV has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
INDV had positive earnings in the past year.
In the past year INDV had a positive cash flow from operations.
In multiple years INDV reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: INDV reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of 8.62%, INDV belongs to the top of the industry, outperforming 90.63% of the companies in the same industry.
INDV has a better Return On Invested Capital (50.62%) than 99.48% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for INDV is significantly above the industry average of 13.48%.
The last Return On Invested Capital (50.62%) for INDV is above the 3 year average (43.06%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.62% | ||
| ROE | N/A | ||
| ROIC | 50.62% |
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
1.3 Margins
INDV has a better Profit Margin (10.34%) than 84.38% of its industry peers.
INDV's Profit Margin has declined in the last couple of years.
INDV's Operating Margin of 24.49% is amongst the best of the industry. INDV outperforms 91.15% of its industry peers.
In the last couple of years the Operating Margin of INDV has remained more or less at the same level.
The Gross Margin of INDV (85.51%) is better than 88.02% of its industry peers.
In the last couple of years the Gross Margin of INDV has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 24.49% | ||
| PM (TTM) | 10.34% | ||
| GM | 85.51% |
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so INDV is creating value.
The number of shares outstanding for INDV has been reduced compared to 1 year ago.
INDV has less shares outstanding than it did 5 years ago.
The debt/assets ratio for INDV is higher compared to a year ago.
2.2 Solvency
INDV has an Altman-Z score of 2.59. This is not the best score and indicates that INDV is in the grey zone with still only limited risk for bankruptcy at the moment.
INDV has a better Altman-Z score (2.59) than 68.23% of its industry peers.
The Debt to FCF ratio of INDV is 2.68, which is a good value as it means it would take INDV, 2.68 years of fcf income to pay off all of its debts.
INDV has a Debt to FCF ratio of 2.68. This is amongst the best in the industry. INDV outperforms 91.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.68 | ||
| Altman-Z | 2.59 |
ROIC/WACC5.44
WACC9.3%
2.3 Liquidity
A Current Ratio of 0.96 indicates that INDV may have some problems paying its short term obligations.
The Current ratio of INDV (0.96) is worse than 84.38% of its industry peers.
INDV has a Quick Ratio of 0.96. This is a bad value and indicates that INDV is not financially healthy enough and could expect problems in meeting its short term obligations.
INDV's Quick ratio of 0.79 is on the low side compared to the rest of the industry. INDV is outperformed by 82.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 239.13% over the past year.
INDV shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -53.19% yearly.
Looking at the last year, INDV shows a decrease in Revenue. The Revenue has decreased by -0.25% in the last year.
The Revenue has been growing by 8.64% on average over the past years. This is quite good.
EPS 1Y (TTM)239.13%
EPS 3Y-75.32%
EPS 5Y-53.19%
EPS Q2Q%94.12%
Revenue 1Y (TTM)-0.25%
Revenue growth 3Y14.52%
Revenue growth 5Y8.64%
Sales Q2Q%2.28%
3.2 Future
Based on estimates for the next years, INDV will show a small growth in Earnings Per Share. The EPS will grow by 5.45% on average per year.
Based on estimates for the next years, INDV will show a small growth in Revenue. The Revenue will grow by 1.28% on average per year.
EPS Next Y-20.5%
EPS Next 2Y-3.84%
EPS Next 3Y2.76%
EPS Next 5Y5.45%
Revenue Next Year-8.5%
Revenue Next 2Y-2.89%
Revenue Next 3Y-0.23%
Revenue Next 5Y1.28%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 16.71, INDV is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of INDV indicates a rather cheap valuation: INDV is cheaper than 84.90% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of INDV to the average of the S&P500 Index (25.45), we can say INDV is valued slightly cheaper.
With a Price/Forward Earnings ratio of 21.27, INDV is valued on the expensive side.
76.04% of the companies in the same industry are more expensive than INDV, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 34.46. INDV is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.71 | ||
| Fwd PE | 21.27 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INDV indicates a rather cheap valuation: INDV is cheaper than 83.33% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of INDV indicates a somewhat cheap valuation: INDV is cheaper than 78.65% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.05 | ||
| EV/EBITDA | 12.19 |
4.3 Compensation for Growth
INDV has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.84%
EPS Next 3Y2.76%
5. Dividend
5.1 Amount
INDV does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
32.75
+0.98 (+3.08%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners94.68%
Inst Owner Change237.52%
Ins Owners3.79%
Ins Owner ChangeN/A
Market Cap4.09B
Revenue(TTM)1.18B
Net Income(TTM)122.00M
Analysts84
Price Target37.45 (14.35%)
Short Float %4.28%
Short Ratio2.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.99%
EPS NY rev (3m)0.99%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.94%
Revenue NY rev (3m)0.94%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.71 | ||
| Fwd PE | 21.27 | ||
| P/S | 3.46 | ||
| P/FCF | 34.05 | ||
| P/OCF | 22.7 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.19 |
EPS(TTM)1.96
EY5.98%
EPS(NY)1.54
Fwd EY4.7%
FCF(TTM)0.96
FCFY2.94%
OCF(TTM)1.44
OCFY4.41%
SpS9.46
BVpS-1.66
TBVpS-1.68
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.62% | ||
| ROE | N/A | ||
| ROCE | 64.08% | ||
| ROIC | 50.62% | ||
| ROICexc | 3805.17% | ||
| ROICexgc | 5707.75% | ||
| OM | 24.49% | ||
| PM (TTM) | 10.34% | ||
| GM | 85.51% | ||
| FCFM | 10.17% |
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)54.5%
ROCE(5y)38.6%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
F-Score8
Asset Turnover0.83
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.68 | ||
| Debt/EBITDA | 0.97 | ||
| Cap/Depr | 230.77% | ||
| Cap/Sales | 5.08% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 57.14% | ||
| Profit Quality | 98.36% | ||
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 2.59 |
F-Score8
WACC9.3%
ROIC/WACC5.44
Cap/Depr(3y)163.83%
Cap/Depr(5y)132.28%
Cap/Sales(3y)2.67%
Cap/Sales(5y)2.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)239.13%
EPS 3Y-75.32%
EPS 5Y-53.19%
EPS Q2Q%94.12%
EPS Next Y-20.5%
EPS Next 2Y-3.84%
EPS Next 3Y2.76%
EPS Next 5Y5.45%
Revenue 1Y (TTM)-0.25%
Revenue growth 3Y14.52%
Revenue growth 5Y8.64%
Sales Q2Q%2.28%
Revenue Next Year-8.5%
Revenue Next 2Y-2.89%
Revenue Next 3Y-0.23%
Revenue Next 5Y1.28%
EBIT growth 1Y8.24%
EBIT growth 3Y11.69%
EBIT growth 5Y7.28%
EBIT Next Year13.79%
EBIT Next 3Y10.08%
EBIT Next 5Y11.81%
FCF growth 1Y236.36%
FCF growth 3Y-74.97%
FCF growth 5Y-48.94%
OCF growth 1Y446.15%
OCF growth 3Y-53.28%
OCF growth 5Y-24.93%
INDIVIOR PLC / INDV FAQ
What is the fundamental rating for INDV stock?
ChartMill assigns a fundamental rating of 5 / 10 to INDV.
Can you provide the valuation status for INDIVIOR PLC?
ChartMill assigns a valuation rating of 5 / 10 to INDIVIOR PLC (INDV). This can be considered as Fairly Valued.
What is the profitability of INDV stock?
INDIVIOR PLC (INDV) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for INDV stock?
The Price/Earnings (PE) ratio for INDIVIOR PLC (INDV) is 16.71 and the Price/Book (PB) ratio is -19.74.
What is the financial health of INDIVIOR PLC (INDV) stock?
The financial health rating of INDIVIOR PLC (INDV) is 4 / 10.